GE HealthCare to announce third quarter 2026 results on October 28, 2026
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
GE HealthCare announces cash dividend increase for third quarter of 2026
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
GE HealthCare Announces CareIntellect for Operations, Helping Health Systems Optimize Resources and Expand Access to Care
GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA
GE HealthCare’s Photonova™ Spectra gains CE Mark, expanding international access
GE HealthCare unveils the next generation of the Vivid cardiovascular ultrasound portfolio, enabling advanced cardiac imaging across care settings
GE HealthCare management to present at upcoming investor conference
GE HealthCare appoints William Grogan as Chief Financial Officer
